[1]
2025. Development and Validation of a Stability Indicating RP-HPLC Method for the Simultaneous Estimation of Trastuzumab and Hyaluronidase-OYSK in Pharmaceutical Dosage Forms: Research Article. Journal of Pharma Insights and Research. 3, 5 (Oct. 2025), 411–419. DOI:https://doi.org/10.69613/phj01412.